What does Parapharmacity do?

Parapharmacity is a pharmacy in Evere. Private Limited, started on 7 October 1991, 1 establishment.

What is the address of Parapharmacity?

The registered office of Parapharmacity is located at Cicerolaan 7, 1140 Evere.

Is Parapharmacity still active?

Yes. According to the CBE (29 October 2026) Parapharmacity is active, legal situation “Normale toestand”, started on 7 October 1991.

Is Parapharmacity registered on Peppol?

Yes, Parapharmacity is registered on the Peppol network with ID 0208:0445338678.

What is the enterprise number of Parapharmacity?

The enterprise number of Parapharmacity is BE0445338678.

When was Parapharmacity founded?

Parapharmacity was founded on 7 October 1991.

Who are the directors of Parapharmacity?

According to the 2025 annual accounts, the directors of Parapharmacity are: MEDI-MARKET GROUP SA.

Is Parapharmacity a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 October 1991; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Parapharmacity make in 2025?

Parapharmacity recorded a loss after taxes of € 11,676 in financial year 2025.

What is the revenue of Parapharmacity?

As a small company, Parapharmacity is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 20,926.

How much does an employee at Parapharmacity earn?

The average wage cost per full-time employee at Parapharmacity was € 11,300 in 2025: staff costs of € 12,418 for 1.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Parapharmacity have?

According to the 2025 annual accounts, Parapharmacity has 1.1 full-time equivalents (FTE).

Parapharmacity (Private Limited) - Evere - BE0445338678

Dossier Parapharmacity, printed on 29 October 2026 from databakkes.be/en/0445338678/parapharmacity. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Shrinking team NBB

FTE fell two years in a row, from 9.6 to 1.1.
Busy address KBO

14 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

Parapharmacity from Evere, company number BE0445338678, closed financial year 2025 with a result of € -11,676 after tax. For that financial year Parapharmacity recorded a gross margin of € 20,926 and equity of € -176,527. Compared with financial year 2024, the result moved from € 18,427 to € -11,676. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Caution

€ -176,527

▼ € 11,676 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -11,676

▼ still € 18,427 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 38

▼ 99% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -195,119.

People and assets in 2025

Full-time equivalents

1.1

▼ 6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 12,418

▼ 96% vs 2024

€ 11,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 6,295

▼ 99% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 66,150

▼ 51% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 323

▼ 99% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 417,467 Gross margin 2022: € 417,467 First fiscal year in the series	€ 607,216 Gross margin 2023: € 607,216 ▲ 45% vs 2022 (€ 417,467) Favourable step	€ 449,728 Gross margin 2024: € 449,728 ▼ 26% vs 2023 (€ 607,216) Unfavourable step	€ 20,926 Gross margin 2025: € 20,926 ▼ 95% vs 2024 (€ 449,728) Unfavourable step	▼ 95%
Profit after taxes	€ -135,390 Profit after taxes 2022: € -135,390 First fiscal year in the series	€ 116,179 Profit after taxes 2023: € 116,179 ▲ € 251,569 vs 2022 (€ -135,390) Favourable step	€ 18,427 Profit after taxes 2024: € 18,427 ▼ 84% vs 2023 (€ 116,179) Unfavourable step	€ -11,676 Profit after taxes 2025: € -11,676 ▼ € 30,103 vs 2024 (€ 18,427) Unfavourable step	▼ € 30,103
Equity	€ -299,456 Equity 2022: € -299,456 First fiscal year in the series	€ -183,278 Equity 2023: € -183,278 ▲ € 116,179 vs 2022 (€ -299,456) Favourable step	€ -164,851 Equity 2024: € -164,851 ▲ € 18,427 vs 2023 (€ -183,278) Favourable step	€ -176,527 Equity 2025: € -176,527 ▼ € 11,676 vs 2024 (€ -164,851) Unfavourable step	▼ € 11,676
Total debts	€ 1,883,139 Total debts 2022: € 1,883,139 First fiscal year in the series	€ 3,426,578 Total debts 2023: € 3,426,578 ▲ 82% vs 2022 (€ 1,883,139) Unfavourable step	€ 3,067,047 Total debts 2024: € 3,067,047 ▼ 10% vs 2023 (€ 3,426,578) Favourable step	€ 2,962,013 Total debts 2025: € 2,962,013 ▼ 3% vs 2024 (€ 3,067,047) Favourable step	▼ 3%
Cash	€ 62,388 Cash 2022: € 62,388 First fiscal year in the series	€ 75,027 Cash 2023: € 75,027 ▲ 20% vs 2022 (€ 62,388) Favourable step	€ 3,265 Cash 2024: € 3,265 ▼ 96% vs 2023 (€ 75,027) Unfavourable step	€ 38 Cash 2025: € 38 ▼ 99% vs 2024 (€ 3,265) Unfavourable step	▼ 99%
Retained profit	€ -318,048 Retained profit 2022: € -318,048 First fiscal year in the series	€ -201,870 Retained profit 2023: € -201,870 ▲ € 116,179 vs 2022 (€ -318,048) Favourable step	€ -183,443 Retained profit 2024: € -183,443 ▲ € 18,427 vs 2023 (€ -201,870) Favourable step	€ -195,119 Retained profit 2025: € -195,119 ▼ € 11,676 vs 2024 (€ -183,443) Unfavourable step	▼ € 11,676
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 500,000 Bank debt 2023: € 500,000 Unchanged (€ 0) Unfavourable step	€ 500,000 Bank debt 2024: € 500,000 Unchanged (€ 500,000) Unchanged	€ 6,295 Bank debt 2025: € 6,295 ▼ 99% vs 2024 (€ 500,000) Favourable step	▼ 99%
Balance sheet total	€ 1,583,683 Balance sheet total 2022: € 1,583,683 First fiscal year in the series	€ 3,243,300 Balance sheet total 2023: € 3,243,300 ▲ 105% vs 2022 (€ 1,583,683) Unchanged	€ 2,902,196 Balance sheet total 2024: € 2,902,196 ▼ 11% vs 2023 (€ 3,243,300) Unchanged	€ 2,785,486 Balance sheet total 2025: € 2,785,486 ▼ 4% vs 2024 (€ 2,902,196) Unchanged	▼ 4%
Employees (FTE)	13.4 Employees (FTE) 2022: 13.4 First fiscal year in the series	9.6 Employees (FTE) 2023: 9.6 ▼ 3.8 vs 2022 (13.4) Unchanged	7.1 Employees (FTE) 2024: 7.1 ▼ 2.5 vs 2023 (9.6) Unchanged	1.1 Employees (FTE) 2025: 1.1 ▼ 6 vs 2024 (7.1) Unchanged	▼ 6

Key figures of Parapharmacity, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Parapharmacity?

What happened at Parapharmacity in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: loss of € 11,676 (▼ € 30,103 vs 2024). Source: NBB ↗
2021 MEDI-MARKET GROUP SA became a director. NBB
Oct 25, 1991 New establishment in Evere. KBO
Oct 7, 1991 Start of the company according to the CBE. KBO

In short

From € 135,390 loss in 2022 to € 11,676 loss in 2025.

Best year ever: 2023, with € 116,179 profit.

On average € 19,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PharmaClic Assets 100%

Parapharmacity

Behind Parapharmacity is MEDI-MARKET GROUP SA. The shares are held by PharmaClic Assets (100%).

Directors

According to the 2025 annual accounts

MEDI-MARKET GROUP SA

Director · represented by Cédric ANTOINE

Owns 100% via PharmaClic Assets

Also active at: Pharmacie by Medi-Market Group – Waterloo Bix, Medi-Market Mons Grand Pré, MEDI-MARKET Parapharmacies, Pharmacie by Medi-Market Group - Gosselies, Pharmacies by Medi-Market Group, Pharmacie by Medi-Market Group - Bruxelles Docks, Pharmacie by Medi-Market Group - Schoten, Pharmacie by Medi-Market Group - Evere +7 more

since 2021

Shareholders

PharmaClic Assets · holding of MEDI-MARKET GROUP SA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Cicerolaan 7

1140 Evere

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.

All companies at this address →

Pharmacie by Medi-Market Group – Waterloo Bix same network

€ 77,722 gross margin · 2025

Medi-Market Mons Grand Pré same network

€ 9,529 gross margin · 2025

MEDI-MARKET Parapharmacies same network

€ 326.6 million revenue · 2025

Pharmacie by Medi-Market Group - Gosselies same network

€ 184,051 gross margin · 2025

Pharmacies by Medi-Market Group same network

€ 61.7 million revenue · 2025

+9 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0445.338.678

VAT number

BE 0445.338.678

Registered office

Cicerolaan 7, 1140 Evere

Names & denominations

Parapharmacity · Paracity

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

7 October 1991

Peppol

Active · Active since 12 Jan 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Parapharmacity

Warning lights

Financials

What happened to Parapharmacity?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions